178 related articles for article (PubMed ID: 19077384)
1. National registries of systemic treatment for psoriasis and the European 'Psonet' initiative.
Lecluse LL; Naldi L; Stern RS; Spuls PI
Dermatology; 2009; 218(4):347-56. PubMed ID: 19077384
[TBL] [Abstract][Full Text] [Related]
2. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
3. European biologicals registers: methodology, selected results and perspectives.
Zink A; Askling J; Dixon WG; Klareskog L; Silman AJ; Symmons DP
Ann Rheum Dis; 2009 Aug; 68(8):1240-6. PubMed ID: 18647854
[TBL] [Abstract][Full Text] [Related]
4. PsoReg--the Swedish registry for systemic psoriasis treatment. The registry's design and objectives.
Schmitt-Egenolf M
Dermatology; 2007; 214(2):112-7. PubMed ID: 17341858
[TBL] [Abstract][Full Text] [Related]
5. The use of ciclosporin in psoriasis: a clinical review.
Ho VC
Br J Dermatol; 2004 May; 150 Suppl 67():1-10. PubMed ID: 15115440
[TBL] [Abstract][Full Text] [Related]
6. Challenges for synthesising data in a network of registries for systemic psoriasis therapies.
Ormerod AD; Augustin M; Baker C; Chosidow O; Cohen AD; Dam TN; Garcia-Doval I; Lecluse LL; Schmitt-Egenolf M; Spuls PI; Watson KD; Naldi L
Dermatology; 2012; 224(3):236-43. PubMed ID: 22678413
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis therapy in real life: the need for registries.
Schmitt-Egenolf M
Dermatology; 2006; 213(4):327-30. PubMed ID: 17135739
[TBL] [Abstract][Full Text] [Related]
8. The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review.
Christophers E; Griffiths CE; Gaitanis G; van de Kerkhof P
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):921-5. PubMed ID: 16922938
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi EA; Krulig E; Gordon KB
Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
[TBL] [Abstract][Full Text] [Related]
10. Long-term data in the treatment of psoriasis.
Thaçi D
Br J Dermatol; 2008 Aug; 159 Suppl 2():18-24. PubMed ID: 18700911
[TBL] [Abstract][Full Text] [Related]
11. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
[TBL] [Abstract][Full Text] [Related]
12. Biological therapies in the systemic management of psoriasis: International Consensus Conference.
Sterry W; Barker J; Boehncke WH; Bos JD; Chimenti S; Christophers E; De La Brassinne M; Ferrandiz C; Griffiths C; Katsambas A; Kragballe K; Lynde C; Menter A; Ortonne JP; Papp K; Prinz J; Rzany B; Ronnevig J; Saurat JH; Stahle M; Stengel FM; Van De Kerkhof P; Voorhees J
Br J Dermatol; 2004 Aug; 151 Suppl 69():3-17. PubMed ID: 15265063
[TBL] [Abstract][Full Text] [Related]
13. Increasing use of more potent treatments for psoriasis.
Strowd LC; Yentzer BA; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2009 Mar; 60(3):478-81. PubMed ID: 19058875
[TBL] [Abstract][Full Text] [Related]
14. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
Kircik L
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
[TBL] [Abstract][Full Text] [Related]
16. [Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology].
Puig L; Bordas X; Carrascosa JM; Daudén E; Ferrándiz C; Hernanz JM; López-Estebaranz JL; Moreno JC; Sánchez-Carazo JL; Vanaclocha F; Vázquez-Veiga H;
Actas Dermosifiliogr; 2009 May; 100(4):277-86. PubMed ID: 19463230
[TBL] [Abstract][Full Text] [Related]
17. Approach to managing patients with nail psoriasis.
Reich K
J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():15-21. PubMed ID: 19686381
[TBL] [Abstract][Full Text] [Related]
18. Calcipotriol and betamethasone dipropionate for the treatment of psoriasis: a 52-week study.
Toole JW
Skin Therapy Lett; 2007 May; 12(4):1-3. PubMed ID: 17551662
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
Puig L
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
[TBL] [Abstract][Full Text] [Related]
20. Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries.
Garcia-Doval I; Rustenbach SJ; Stern R; Dam TN; Cohen AD; Baker C; Spuls PI; Naldi L;
Br J Dermatol; 2013 Sep; 169(3):710-4. PubMed ID: 23551034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
